Viewpoint: Preclinical Alzheimer Disease—Early Diagnosis or Overdiagnosis?
12 Jul, 2019 | 07:52h | UTCPreclinical Alzheimer Disease—Early Diagnosis or Overdiagnosis? – JAMA Internal Medicine (free for a limited period)
Related Commentary on Twitter
Preclinical #AlzheimerDisease: may identify high-risk group to target new preventive medications, but may also lead to overdiagnosis and high costs https://t.co/GK3soETwd1
— JAMA Internal Medicine (@JAMAInternalMed) July 9, 2019